Transplantation of microencapsulated cells expressing VEGF improves angiogenesis in implanted xenogeneic acellular dermis on wound (Q42824750)

8 November 2017

title

Transplantation of microencapsulated cells expressing VEGF improves angiogenesis in implanted xenogeneic acellular dermis on wound (English)

1 reference

8 November 2017

1 reference

Y-F Han

1

1 reference

8 November 2017

Y-Q Han

2

1 reference

8 November 2017

Y-G Pan

3

1 reference

8 November 2017

Y-L Chen

4

1 reference

8 November 2017

J-K Chai

5

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Transplantation Proceedings

8 November 2017

published in

1 reference

8 November 2017

volume

42

1 reference

8 November 2017

issue

5

1 reference

8 November 2017

page(s)

1935-1943

1 reference

Use of porcine acellular dermal matrix as a dermal substitute in rats

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Comparison of histological structure and biocompatibility between human acellular dermal matrix (ADM) and porcine ADM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

The role of vascular endothelial growth factor in wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Immuno-isolation in cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Delivery of recombinant gene products with microencapsulated cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Cell and gene therapy in the treatment of pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Microencapsulation of recombinant cells: a new delivery system for gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Transplantation of encapsulated cells and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Microencapsulation and tissue engineering as an alternative treatment of diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Virus treatment questioned after gene therapy death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Cell-based gene therapy for the prevention and treatment of cardiac dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Timing and targeting of cell-based VEGF165 gene expression in ischemic tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Gene transfer and living release of transforming growth factor-beta3 for cartilage tissue engineering applications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Regulable vascular endothelial growth factor165 overexpression by ex vivo expanded keratinocyte cultures promotes matrix formation, angiogenesis, and healing in porcine full-thickness wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Microencapsulated islets as bioartificial endocrine pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Therapeutic applications of polymeric artificial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Cell-based therapies go live

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

In vivo recognition by the host adaptive immune system of microencapsulated xenogeneic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Cardiovascular gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Gene therapy for cartilage defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Investigation of a new microcapsule membrane combining alginate, chitosan, polyethylene glycol and poly-L-lysine for cell transplantation applications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.070

10.1016/J.TRANSPROCEED.2009.12.070

7 January 2021

Identifiers

DOI

1 reference

8 November 2017

1 reference